Processing naproxen with supercritical CO2

Naproxen has been processed with supercritical fluids in order to improve the dissolution rate and bioavailability. Microparticles of naproxen have been obtained by a Rapid Expansion of Supercritical Solutions (RESS) process in which carbon dioxide has been used as a solvent and methanol as a cosolvent. The influence of extraction pressure (200–300 bar) and extraction temperature (60 °C and 100 °C) on the naproxen precipitation has also been investigated. In general, the morphology of the precipitated particles improved and particle size (PS) decreased in comparison to the raw material. Lower extraction pressure and higher extraction temperature led to a smaller particle size. On the other hand, a supercritical antisolvent (SAS) process has been applied due to the relative medium solubility values of naproxen in supercritical carbon dioxide, with precipitation obtained successfully in all cases. The initial concentration of the solution and the solvent effect has both been analysed. Morphologies and mean diameter ranges have been analysed by scanning electron microscopy (SEM) and the influence on crystallinity of both supercritical processes has been evaluated by X-ray diffraction (XRD) measurements.     

Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes

In the case of pharmaceutical substances the particle size is quite important since it can limit the bioavailability of poorly soluble drugs. As an example we can refer to the data obtained for Griseofulvin. In 1962 Atkinson has studied the concentration of the drug in the blood, taken from healthy volunteers at given intervals of time after dosing, as a function of its specific area. The quantity absorbed for a particle size of 2.7 μm is twice as high compared with a particle size of 10 μm. The present article gives a survey of published knowledge about particle and product design with focus on the RESS process and some promising modifications of this technique. Experimental results confirm that each of these processes is a promising technique for the formation of submicron particles (≤100 nm) and that the improved dissolution behaviour is influenced by particle size, surface area, and wettability of the processed powders as well as by the pH-value of the dissolution media.     

Precipitation kinetics of PMMA sub-micrometric particles with a supercritical assisted-atomization process

Sub-micrometric particles of PMMA were successfully prepared via a supercritical assisted-atomization (SAA) process using acetone as a solvent and supercritical carbon dioxide as a spraying medium. The effects of several key factors on the particle size were investigated. These factors included the concentration of polymer solution, temperature in saturator and volumetric flow rate ratio of carbon dioxide to polymer solution. The shape of the polymer's primary particles is spherical with the arithmetic mean size ranging from 82 nm to 176 nm and the mass-weighted mean size ranging from 127 nm to 300 nm. As evidenced from the experimental results, the lower concentrations of polymer solution, optimized volumetric flow rate ratios, and higher temperatures in saturator can effectively reduce the mean particle size. The precipitation kinetic parameters were determined from the particle size distributions with the aid of the population balance theory. This study found the primary nucleation to be dominant in the precipitation and diffusion may govern particle growth.     

Supercritical antisolvent micronization of PVP and ibuprofen sodium towards tailored solid dispersions

The supercritical antisolvent technology is used to precipitate polyvinylpyrrolidone (PVP) particles and crystallise ibuprofen sodium (IS) crystals separately and in the form of solid dispersion together. Supercritical carbon dioxide (scCO₂) is used as antisolvent. For PVP particle generation, ethanol, acetone and mixtures of ethanol and acetone are used as solvents. The initial concentration of PVP in the solution was varied between 0.5 wt% and 1.5 wt%, the operation pressure between 10 MPa and 30 MPa and the composition of ethanol/acetone solvent mixtures between 100 wt% and 0 wt% of ethanol at a constant temperature of 313 K. Furthermore, the mean molecular weight of the polymer was varied between 40 kg mol⁻¹, 360 kg mol⁻¹ and 1300 kg mol⁻¹. An increase of the content of the poor solvent acetone in the initial solvent mixture as well as the usage of PVP with a higher molecular weight, leads to a significant decrease in mean particle size. At all the investigated parameters always fully amorphous PVP powder precipitates. For IS, only ethanol was used as the solvent, the initial IS concentration in the solution was varied between 1 wt% and 3 wt% and the operation pressure between 10 MPa and 16 MPa. A variation of these parameters leads to a manipulation of the size and the morphology of the crystallised IS crystals. Irrespective of the parameters used, always the same polymorphic form of ibuprofen sodium is produced. The solid dispersions were generated at different compositions of PVP to IS and with two different molecular weights of PVP at otherwise constant conditions. Fully amorphous solid dispersions consisting of IS and PVP together were generated at different ratios of PVP to IS.The mechanisms that control the final particle properties are discussed taking into account two different models for “ideal” and “non-ideal” solutes. Furthermore, the study of the “unconventional” SAS parameters, molecular weight and solvation power of the solvent shows that these parameters qualify to tailor polymer particle properties via SAS processing. Next to the investigation into the behaviour of both solutes separately, fully amorphous solid dispersions consisting of IS and PVP together were generated. While X-ray diffraction was used to analyze the crystalline structure of the particles, respectively, solid dispersions, their morphology was analysed using scanning electron microscopy (SEM).     

Formation and stabilization of submicron particles via rapid expansion processes

Submicron particles were produced by rapid expansion of supercritical solution into air (RESS) or an aqueous surfactant solution (RESSAS) to minimize particle growth and to prevent particle agglomeration. Thereby the effect of process conditions on the size of the particles precipitated was investigated. The obtained product was evaluated by measuring particle size by 3-wavelength extinction measurements, dynamic light scattering, specific surface areas by nitrogen gas adsorption, melting behaviour by differential scanning calorimetry, particle morphology by X-ray diffraction, scanning electron micrographs (SEM), and drug loading by high performance liquid chromatography.Prior to the particle formation experiments, the melting temperature of Salicylic acid under CO₂ pressure and the solubility of Salicylic acid in CO₂ were measured. The size of Salicylic acid particles produced via RESS decreased from 230 to 130 nm as the pre-expansion temperature decreased from 388 to 328 K and the specific surface area of the micronized particles was found to be up to 60 times higher than that of the unprocessed material. RESSAS experiments demonstrate that in 1 wt.% Tween 80 solutions Salicylic acid concentrations of 4.6 g/dm³ could be stabilized with particle diameters in the range of 180 nm. Additional experiments show that Ibuprofen nanoparticles with an average size of 80 nm and a drug concentration of 2.4 g/dm³ could be stabilized in 1 wt.% Tween^® 80 solutions. The use of a SDS solution instead of Tween^® 80 results in a stable aqueous suspension of phytosterol nanoparticles, where the average particle size is 50 nm at a drug concentration of 5.6 g/dm³.     

Synthesis of a biocompatible polymer using siloxane-based surfactants in supercritical carbon dioxide

Poly(N-vinyl-2-pyrrolidone) (PVP) particles were prepared by dispersion polymerization in the presence of 2,2′-azobisisobutyronitrile as the initiator and siloxane-based surfactant in supercritical carbon dioxide (scCO₂). The dispersants used in this study were non-ionic, non-reactive and commercially produced siloxane-based surfactants (Monasil PCA and KF-6017). We investigated the effect of kinds and concentrations of the surfactants, in addition to the reaction temperature and the concentration of the monomer on the particle size and morphology. PVP microspheres were prepared in 0.23–0.74 μm size range with Monasil PCA and 0.71–1.98 μm size range with KF-6017, respectively. The resulting polymer particle of >90% yield was obtained. Particle size slightly increased with the amount of monomer in polymerization with Monasil PCA. In the case of KF-6017 as the surfactant, there was not an obvious variation in particle size with increasing monomer. Particle size of PVP decreased as surfactant concentration increased from 5.0 to 15.0 wt.% basis on concentration of monomer. The narrow particle size distribution (D_n = 0.23 μm and PSD = 1.06) was presented at the high concentration of Monasil PCA (15 wt.% on monomer concentration). As indicated by the reaction temperature and the addition of organic solvent, which affected solubility of monomer, polymer and surfactant in scCO₂, particle size and particle size distribution of PVP varied. PVP particles with Monasil PCA strongly aggregated at 75 °C in contrast to KF-6017 which showed discrete particles at 65 and 70 °C, but particle size distribution was broad. Particle size was slightly reduced with a little amount of hexane, with an inverse relationship of adding hexane reduced the particle size. The amount of the relative residual surfactants on surface of the polymer after extracting with supercritical fluid process (SFE) was measured by using SEM/EDS and EPMA analysis to map out the distribution of silicon element qualitatively. The original polymer particle before the extraction using CO₂ had the high level of silicon element, but the average level of silicon element became low after CO₂ extraction.     

Supercritical anti-solvent micronization of marigold-derived lutein dissolved in dichloromethane and ethanol

This work aims to study supercritical anti-solvent (SAS) micronization of lutein derived from marigold flowers. Lutein solution in dichloromethane (DCM) or ethanol was atomized into the stream of supercritical carbon dioxide (SC-CO₂) through a concentric nozzle in a pressurized vessel. The effects of pressure and SC-CO₂ flow rate on morphology, mean particle size (MPS) and particle size distribution (PSD) were investigated. The reduction in lutein MPS from 202.3 μm of unprocessed lutein to 1.58 μm and 902 nm could be achieved by SAS micronization using DCM and ethanol, respectively. In both solvent systems, no significant effects of pressure and SC-CO₂ flow rate on particle morphology were observed. However, pressure was found to have a significant effect on MPS and PSDs of lutein particles.     

Synthesis of dispersed CaCO3 nanoparticles by the ultrafine grinding

A one-step grinding process to obtain CaCO₃ nanoparticles from a micrometer-sized CaCO₃ was studied. A high-speed beads mill was employed to grind the particles, and poly(acrylic acid, sodium salt) was used to disperse the ground particles. The main parameters, which were investigated, were the slurry concentration, the rotor speed, the bead size, and the surfactant concentration. The larger bead size, higher slurry concentration, and faster rotor speed showed higher grinding efficiencies. However, there was severe agglomeration of the ground particles resulting in larger secondary particles as the grinding time increased after the certain point. The dispersion and enhanced grinding of particles were achieved by the surfactant. The particle size distribution of the ground particles had a narrow peak around 190 nm that was measured by the diffraction method. The primary particle size of the ground particles was around 40 nm.     

Micronization of ketoprofen by the rapid expansion of supercritical solution process

The particle size of the pharmaceutical substances is important for their bioavailability (the percentage of the drug absorbed compared to its initial dosage). The absorption rate can be increased by reducing particle size of the drug particles. This study was conducted to investigate the effects of the extraction pressure (140–220 bar), extraction temperature (308–338 K), nozzle length (2–15 mm), effective nozzle diameter (450–1700 μm), and collection distance (1–10 cm) on the size and morphology of the precipitated ketoprofen particles. The characterization (size and morphology) of the particles was investigated using scanning electron microscopy (SEM). The average particle size of the original material was 115.42 μm, while the average particle size of the micronized particles is between 0.35 and 7.03 μm near to quisi-spherical, needle and irregular shape depending upon the experimental conditions.     

Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS)

The particle sizes of the pharmaceutical substances are important for their bioavailability. The bioavailability can be improved by reducing the particle size of the drug. In this study, salicylic acid and taxol were micronized by the rapid expansion of supercritical fluids (RESS). Supercritical CO₂ and CO₂ + ethanol mixture were used as solvent. Experiments were carried out to investigate the effect of extraction temperature (318–333 K) and pressure (15–25 MPa), pre-expansion temperature (353–413 K), expansion chamber temperature (273–293 K), spray distance (6–13 cm), co-solvent concentration (ethanol, 1, 2, 3, v/v, %) and nozzle configuration (capillary and orifice nozzle) on the size and morphology of the precipitated salicylic acid particles. For taxol, the effects of extraction pressure (25, 30, 35 MPa) and co-solvent concentration (ethanol, 2, 5, 7, v/v, %) were investigated. The characterization of the particles was determined by scanning electron microscopy (SEM), optical microscopy, and LC–MS analysis.The particle size of the original salicylic acid particles was L/D: 171/29–34/14 μm/μm. Depending upon the different experimental conditions, smaller particles (L/D: 15.73/4.06 μm/μm) were obtained. The particle size of taxol like white crystal powders was reduced from 0.6–17 μm to 0.3–1.7 μm The results showed that the size of the precipitated salicylic acid and taxol particles were smaller than that of original particles and RESS parameters affect the particle size.     

Synthesis of 5-Fluorouracil nanoparticles via supercritical gas antisolvent process

The micronization of an anticancer compound (5-Fluorouracil) by supercritical gas antisolvent (GAS) process was investigated. 5-Fluorouracil was dissolved in dimethyl sulfoxide (DMSO) and subsequently carbon dioxide as an antisolvent was injected into this solution thus, the solution was supersaturated and nanoparticles were precipitated. The influence of antisolvent flow rate (1.6, 2 and 2.4 mL/min), temperature (34, 40 and 46), solute concentration (20, 60 and 100 mg/mL) and pressure (9, 12 and 15 MPa) on particle size and particle size distribution were studied. Particle analyses were performed by scanning electron microscopy (SEM) and Zetasizer Nano ZS. The mean particle size of 5-Fluorouracil was obtained in the range of 260–600 nm by varying the GAS effective parameters. The High performance liquid chromatography (HPLC) and Fourier transforms infrared spectroscopy (FTIR) analyses indicated that the 5-Fluorouracil nanoparticles were pure and the nature of the component did not change. The experimental results indicated that increasing the antisolvent flow rate and pressure, while decreasing the temperature and initial solute concentration, led to a decrease in 5-Fluorouracil particle size.     

Dense CO2 antisolvent precipitation of levothyroxine sodium: A comparative study of GAS and ARISE techniques based on morphology and particle size distributions

Morphology and particle size distribution of levothyroxine sodium are experimentally investigated by comparing gas antisolvent (GAS) and atomized rapid injection for solvent extraction (ARISE) techniques using dense CO₂. Precipitation of levothyroxine sodium from ethanol was carried out at 25, 40 and 50 °C, with pressure in the 90–120 bar range and different concentrations of the organic solution. Particles produced by the GAS process are nanospheres whereas ARISE processed particles are either spherical or rod-like micro and nanoparticles. Particle size and size distributions of GAS processed levothyroxine sodium are in the 370–500 nm range, while the ARISE process produced particles in the 360–1200 nm range. In most cases, both techniques produced bimodal size distributions, due to particle agglomeration. The different morphological characteristics and particle size distributions of levothyroxine sodium obtained using GAS and ARISE at different operating conditions can be useful depending on the type of drug formulation chosen, as well as the route of drug administration and delivery system.     

Preparation of poly-lactic acid nano/microparticles using supercritical anti-solvent with enhanced mass transfer

Supercritical anti-solvent precipitation with enhanced mass transfer (SAS-EM) was applied for the production of micro and sub-microparticles of poly-lactic acid (PLA). SAS-EM technique uses an ultrasonic vibrating surface to enhance mass transfer rate between supercritical CO₂ and solvent. Without applying ultrasonic power, which is same as SAS process, PLA particles with average diameters ranging between 1 μm and 3 μm were obtained. Using SAS-EM with the power supply of 200 W, spherical PLA particles smaller than 1 μm were obtained. The particle size was able to be controlled in the range of 0.4 μm–1.0 μm, by adjusting the power supply of ultrasonic field, the system pressure and temperature.     

Experimental investigation on the micronization of aqueous cefadroxil by supercritical fluid technology

The supercritical-assisted atomization (SAA) process is a novel technique proposed recently to prepare micro-particles with controlled particles size distribution suitable for aerosolizable delivery. It has shown a great potential in drug micronization especially for water-soluble drugs. Cefadroxil micro-particles were prepared successfully from water–ethanol mix-solvent by SAA process. The influence of the operation parameters, including the pressure and temperature in the mixing vessel, the solution concentration and the solution feed rate, on the particle morphology, size and size distribution was investigated in detail. The results show that the concave cefadroxil micro-particles suitable for pulmonary drug delivery could be prepared by SAA process in certain conditions. The pressure in the mixing vessel and the solution feed rate are two most effective parameters while the solution concentration is the next. The temperature in the mixing vessel has a little effect. The particle characteristics could be controlled by adjusting operation conditions. The optimal operation parameters for preparing cefadroxil micro-particles in the scope of this work are: the pressure of 10 MPa and the temperature of 60 °C in the mixing vessel, the solution feed rate of 3 ml/min, and the solution concentration of 4 mg/ml.     

Process intensification approach for preparation of curcumin nanoparticles via solvent–nonsolvent nanoprecipitation using spinning disc reactor

Continuous preparation of curcumin nanoparticles via solvent–nonsolvent (S-NS) precipitation by using spinning disc reactor was investigated. The process intensification by spinning disc reactor (SDR) along with the comparative study of conventional mechanical agitated contactor was carried out. Solvent used for curcumin precipitation in this study was ethanol whereas non-solvent deionised water. Influences of various operating parameters for spinning disc process; such as flow rate of S-NS, S-NS ratio, concentration of curcumin, disc characteristics, concentration of protecting agent and rotating disc speed were examined on the nanoparticles size. The average optimum curcumin particles size was obtained in the range 180–220 nm in consideration with particles size distribution at a flow rate of 200 mL min⁻¹; curcumin concentration of 0.5 g L⁻¹ in ethanol; polyvinylpyrilodine (PVP) concentration of 1 g L⁻¹ in deionised water; S:NS ratio 1:4 and operating disc speed of 1500 rpm. Particles were characterized by using XRD, FT-IR, DSC and SEM which showed decrease in the crystallinity after the nanoprecipitation of curcumin. The dissolution rates of the fabricated curcumin nanoparticle were found drastically higher than original curcumin.     

Filtration of fly ash using fluidized bed at 300–500 °C

The filtration of the coal-burning fly ash using fluidized beds with silica sand of 770 μm under temperatures of 36, 300, 400, and 500 °C was studied. The variations of the outlet concentration and particle size distribution (PSD) with time were measured to evaluate the dynamic characteristics of the process. Experimental results showed that the overall collection efficiency decayed with the operation time, revealed the effect of the elutriation of fly ash on particle filtration. The collection efficiency rose when the temperature increased from 36 °C to 500 °C. The strong attrition at high temperature released more small particles than that at room temperature, increased the concentration of the particles less than 10 μm (PM₁₀) at high temperature. The removal efficiency of the particles in a size of 4–7 μm, not the submicron particles, is the lowest because they are most easily elutriated from fluidized beds.     

Amorphization of pharmaceutical compound by co-precipitation using supercritical anti-solvent (SAS) process (Part I)

The aim of this work is to investigate the feasibility of using supercritical anti-solvent (SAS) co-precipitation process to influence the crystallinity or amorphous character of a crystalline non-steroidal anti-inflammatory drug (NSAID), indomethacin (IDMC) for solubility enhancement. Co-precipitations of IDMC and the water-soluble polymer excipient poly(vinylpyrrolidone) (PVP) have been prepared by SAS. The SAS co-precipitates with drug to polymer ratios of 85:15, 50:50 and 20:80 were generated using supercritical carbon dioxide as anti-solvent. The untreated and SAS powders (before and after storage) were characterised using scanning electron microscopy (SEM, morphology), powder X-ray diffractometry (PXRD, crystallinity), USP dissolution tester and thermogravimetric analysis. In addition, stability stress tests on SAS co-precipitates on open pans were carried out at 75% RH and room temperature or 40 °C in order to evaluate their physical stability. SAS co-precipitates with PVP contents more than 50 wt.% were X-ray amorphous and remained stable after 7 months storage at 75% RH and room temperature or 40 °C. It was demonstrated that the drug to polymer ratio influenced amorphous content of the SAS co-precipitates. By using different polymer ratios, the morphologies of a drug–polymer composite can be varied. TGA analyses revealed that the composition of SAS co-precipitates were consistent with the experimentally designed composition. Amorphous form of IDMC produced by SAS has improved dissolution properties as compared to the crystalline form. This form is also stable under stress test conditions compared as with spray-dried amorphous indomethacin. It is suggested that PVP excipient could be a suitable “amorphous inducing and stabilizing” agent for SAS process.     

Micronization of fenofibrate by rapid expansion of supercritical solution

Micronization of fenofibrate was investigated using rapid expansion of supercritical solution (RESS) process. Effects of pressure, temperature and nozzle on particle size were optimized using Taguchi's orthogonal array and analyzed using XRD, DSC, FT-IR, SEM, laser diffractometer and dissolution testing. Processed fenofibrate retained crystalline structure and has a similar chemical structure with unprocessed fenofibrate. The average particle size of fenofibrate was reduced from its original 68.779 ± 0.146 μm to 3.044 ± 0.056 μm under the optimum condition (T at 35 °C, P at 200 bar and nozzle diameter at 200 μm). The processed fenofibrate showed an enhanced dissolution rate by 8.13 times.     

Production of fermentable sugars from enzymatic hydrolysis of pretreated municipal solid waste after autoclave process

A ligno-cellulosic concentrate from municipal solid waste (MSW) obtained after an autoclave separation process was investigated for its potential as a feedstock to produce fermentable sugars for ethanol production. A maximum enzymatic hydrolysis conversion of 53% of the cellulose and hemi-cellulose was found using a particle size range of 150–300 μm hydrolyzed in a 100 ml buffer solution containing 6 wt% lingo-cellulosic MSW concentrate with 90 mg cellulase at pH 4.8 held at 40 °C for 12 h. The hydrolysis rate leveled off at longer hydrolysis time and with increased substrate concentration and was related to enzymatic access to substrate. Lower hydrolysis rate at smaller particle size indicates that the grinding process may change the surface chemistry or morphology of the fibers making them less available for enzyme access. A drop in the hydrolysis rate was observed for the particles above 300 μm associate with the longer diffusion time for the enzyme into the fiber particles. The findings indicate that 152 L of ethanol could be obtained from a ton of lingo-cellulosic concentrate from MSW.     

Kinetics of magnetite nanoparticles formation in a one step low temperature hydrothermal process

In the present study, a one step hydrothermal process was employed to synthesize magnetite nanoparticles using oleic acid as surfactant agent at 140 °C. Effects of reaction time and alkalinity were studied on particles size and morphology. By changing these parameters, some monodisperse spherical nanoparticles with mean particle size between 2.71 and 13.88 nm were synthesized and characterized via TEM, XRD, VSM, TGA and FT-IR techniques. Assuming the Avrami behavior of particles formation, a kinetics equation was proposed for the transformation rate at 140 °C. Using some simplifying assumptions, nucleation and growth rates were calculated for the hydrothermal formation of magnetite nanoparticles at 140 °C.